Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343065 · ClinicalTrials.gov registry record · NA
A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B
A NA study of Diabetes Mellitus, sponsored by Welldoc.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT05343065 is a NA study of Diabetes Mellitus that has completed, run by Welldoc. The registered enrollment target is 27 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05343065, a NA study of Diabetes Mellitus, has completed, sponsored by Welldoc.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor.
Conditions Studied
Interventions
- DEVICE BlueStar 10
Study Locations (1)
Maryland
- MedStar Health Research Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05343065
The ClinicalTrials.gov registry entry for NCT05343065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Welldoc, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which BlueStar 10 is the first listed.
NCT05343065 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05343065 about?
NCT05343065 is a clinical study titled "A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B". This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor.
What is the current status of trial NCT05343065?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2022-07-05. Estimated completion is 2022-12-20.
What conditions does trial NCT05343065 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT05343065?
The interventions under investigation include: BlueStar 10 (DEVICE).
Who is sponsoring clinical trial NCT05343065?
This trial is sponsored by Welldoc, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05343065 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.